Description
Retatrutide 20mg | Triple Receptor Agonist (GLP-1, GIP & Glucagon)
IMPORTANT — RESEARCH USE ONLY
Retatrutide is supplied as a lyophilized peptide powder intended exclusively for scientific and laboratory research purposes (Research Use Only — RUO).
This material is not intended for human or veterinary use, human consumption, diagnostic procedures, or therapeutic applications.
Also Known As: Retatrutide, Triple G Agonist, Triple Incretin Agonist
PRODUCT OVERVIEW
Retatrutide is a synthetic peptide currently under investigation for its activity as a triple receptor agonist targeting the GLP-1 (Glucagon-Like Peptide-1), GIP (Glucose-Dependent Insulinotropic Polypeptide), and glucagon receptors.
Its simultaneous activity across three metabolically relevant receptor pathways has made retatrutide a compound of interest in research involving receptor pharmacology, metabolic regulation, energy homeostasis, endocrine signaling, glucose metabolism, and energy expenditure.
Experimental studies may investigate receptor activation, downstream intracellular signaling, metabolic pathways, structure–activity relationships, and other mechanisms associated with multi-receptor agonism under controlled laboratory conditions.
Each vial contains 20mg of Retatrutide in lyophilized form.
RESEARCH APPLICATIONS
- GLP-1, GIP, and glucagon receptor pharmacology
- Multi-receptor agonist research
- Receptor activation and intracellular signaling studies
- Metabolic regulation and energy homeostasis research
- Hormonal and endocrine signaling investigations
- Cell-based receptor signaling assays
- Preclinical metabolic research models
- Glucose metabolism and energy expenditure studies
- Structure–activity relationship (SAR) research
PRODUCT SPECIFICATIONS
- Product Name: Retatrutide
- Active Ingredient: Retatrutide
- Chemical Formula: C₂₂₁H₃₄₂N₄₆O₆₈
- Appearance: White to off-white lyophilized powder
- Physical Form: Lyophilized Powder
- Quantity: 20mg per vial
- Product Classification: Research Use Only (RUO)
- Packaging: Sealed research vial
STORAGE & HANDLING
- Long-Term Storage: Store at −20°C in the original sealed container for optimal long-term stability.
- Short-Term Storage: Store refrigerated at 2–8°C for up to a few months.
- Protect from direct light, excessive heat, and moisture.
- Keep the vial tightly sealed during storage.
- Minimize unnecessary temperature fluctuations.
- Avoid repeated freeze–thaw cycles.
- After Reconstitution: Store refrigerated at 2–8°C and avoid repeated temperature cycling.
- Shelf Life: Up to 24 months from the date of manufacture when stored under the recommended long-term storage conditions.
RESEARCH SAFETY INFORMATION
Retatrutide remains an investigational compound and continues to undergo scientific and clinical evaluation.
Published clinical research has reported adverse events associated with retatrutide, with gastrointestinal events among those observed, including:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Abdominal discomfort
- Decreased appetite
Scientific Information Notice: The information above is provided solely as a summary of observations reported in scientific research. It does not constitute medical advice, dosing guidance, treatment recommendations, or instructions for human use.
REGULATORY & RESEARCH USE NOTICE
FOR RESEARCH USE ONLY. NOT FOR HUMAN OR VETERINARY USE.
This product is intended solely for scientific and laboratory research.
Retatrutide is an investigational compound and is not supplied as an approved medicinal product. It is not intended for human consumption, diagnosis, treatment, prevention of disease, or any clinical or therapeutic application.
Purchasers are responsible for ensuring that the purchase, possession, storage, handling, and use of this material comply with all applicable laws, regulations, institutional requirements, and laboratory safety procedures.
